Jiang, H., Shi, Z., Wang, P., Wang, C., Yang, L., Du, G., . . . Li, Z. (2019). Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer. JNCI : Journal of the National Cancer Institute, 111(4), 409. https://doi.org/10.1093/jnci/djy134
Citace podle Chicago (17th ed.)Jiang, Hua, et al. "Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer." JNCI : Journal of the National Cancer Institute 111, no. 4 (2019): 409. https://doi.org/10.1093/jnci/djy134.
Citace podle MLA (9th ed.)Jiang, Hua, et al. "Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer." JNCI : Journal of the National Cancer Institute, vol. 111, no. 4, 2019, p. 409, https://doi.org/10.1093/jnci/djy134.